X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7717) 7717
Publication (831) 831
Book Chapter (36) 36
Book Review (20) 20
Conference Proceeding (7) 7
Book / eBook (5) 5
Dissertation (5) 5
Data Set (4) 4
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (5264) 5264
neurosciences (4547) 4547
male (4237) 4237
neostriatum (4223) 4223
rats (3685) 3685
index medicus (3198) 3198
dopamine (2955) 2955
neostriatum - drug effects (2288) 2288
brain (2226) 2226
neostriatum - metabolism (2223) 2223
rats, sprague-dawley (1621) 1621
mice (1511) 1511
neurons (1483) 1483
dopamine - metabolism (1447) 1447
female (1418) 1418
humans (1395) 1395
striatum (1370) 1370
basal ganglia (1283) 1283
cortex (1229) 1229
rodents (1224) 1224
parkinson's disease (1217) 1217
rats, wistar (1045) 1045
pharmacology & pharmacy (1006) 1006
neuroscience (984) 984
neurodegenerative diseases (955) 955
dopamine receptors (894) 894
nervous system (880) 880
psychiatry (874) 874
neurology (853) 853
movement disorders (844) 844
parkinsons-disease (808) 808
neurons - drug effects (793) 793
multidisciplinary sciences (755) 755
medicine (740) 740
research article (707) 707
article (684) 684
science (681) 681
neuroimaging (664) 664
neostriatum - physiology (658) 658
disease models, animal (650) 650
nucleus-accumbens (650) 650
corpus striatum - metabolism (641) 641
immunohistochemistry (641) 641
reinforcement (638) 638
magnetic resonance imaging (619) 619
neurons - metabolism (615) 615
animal models (602) 602
analysis (598) 598
substantia nigra (593) 593
neostriatum - cytology (582) 582
proteins (581) 581
corpus striatum - drug effects (577) 577
adult (566) 566
rat (563) 563
receptors (556) 556
mice, inbred c57bl (555) 555
nucleus accumbens (547) 547
biochemistry & molecular biology (536) 536
dose-response relationship, drug (532) 532
gene expression (531) 531
microdialysis (528) 528
behavior (516) 516
mental disorders (513) 513
motor activity - drug effects (511) 511
hippocampus (510) 510
behavior, animal - drug effects (506) 506
prefrontal cortex (503) 503
neurodegeneration (502) 502
cocaine (500) 500
brain research (497) 497
reward (486) 486
studies (482) 482
cognitive ability (481) 481
in-vivo (473) 473
oxidative stress (461) 461
schizophrenia (459) 459
biomedicine (458) 458
research (445) 445
neurotoxicity (441) 441
glutamate (440) 440
dopamine d2 receptors (434) 434
neostriatum - pathology (434) 434
substantia-nigra (434) 434
neuroprotection (432) 432
biology (427) 427
in vitro techniques (421) 421
amphetamine (419) 419
brain - metabolism (411) 411
dopamine - physiology (407) 407
brain mapping (403) 403
parkinsons disease (402) 402
expression (393) 393
cell biology (390) 390
clinical neurology (389) 389
drug abuse (389) 389
activation (388) 388
serotonin (388) 388
functional magnetic resonance imaging (382) 382
phenols (381) 381
brain - drug effects (375) 375
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7694) 7694
Russian (51) 51
Japanese (22) 22
Chinese (8) 8
Ukrainian (3) 3
French (2) 2
German (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Neuroscience, ISSN 0270-6474, 03/2010, Volume 30, Issue 9, pp. 3398 - 3408
Striatal dopamine (DA) and acetylcholine (ACh) regulate motivated behaviors and striatal plasticity. Interactions between these neurotransmitters may be... 
KNOCK-OUT MICE | MEDIATED MODULATION | PRIMATE STRIATUM | M2-MUSCARINIC DRUGS | MIDBRAIN DOPAMINE | LONG-TERM POTENTIATION | AUTORECEPTOR FUNCTION | NICOTINIC ACETYLCHOLINE-RECEPTORS | NEUROSCIENCES | CAT CAUDATE-NUCLEUS | MONKEY STRIATUM | Receptor, Muscarinic M2 - genetics | Synaptic Transmission - physiology | Muscarinic Agonists - pharmacology | Nucleus Accumbens - metabolism | Basal Ganglia - metabolism | Receptor, Muscarinic M2 - drug effects | Electrophysiology | Receptors, Muscarinic - metabolism | Acetylcholine - metabolism | Corpus Striatum - cytology | Corpus Striatum - metabolism | Basal Ganglia - cytology | Receptors, Muscarinic - drug effects | Neostriatum - drug effects | Nucleus Accumbens - cytology | Neostriatum - metabolism | Synaptic Transmission - drug effects | Interneurons - cytology | Receptor, Muscarinic M4 - genetics | Dopamine - metabolism | Organ Culture Techniques | Receptors, Muscarinic - genetics | Receptors, Nicotinic - drug effects | Receptors, Nicotinic - metabolism | Neostriatum - cytology | Presynaptic Terminals - drug effects | Receptor, Muscarinic M2 - metabolism | Mice, Inbred C57BL | Interneurons - drug effects | Receptor, Muscarinic M4 - metabolism | Mice, Knockout | Patch-Clamp Techniques | Animals | Interneurons - metabolism | Receptor, Muscarinic M4 - drug effects | Corpus Striatum - drug effects | Presynaptic Terminals - metabolism | Mice | Nucleus Accumbens - drug effects | Basal Ganglia - drug effects
Journal Article
Cell Metabolism, ISSN 1550-4131, 02/2017, Volume 25, Issue 2, pp. 335 - 344
Journal Article
Nature Communications, ISSN 2041-1723, 2013, Volume 4, Issue 1, pp. 2373 - 2373
Journal Article
Neuron, ISSN 0896-6273, 2004, Volume 42, Issue 4, pp. 653 - 663
Dopamine input to the striatum is required for voluntary motor movement, behavioral reinforcement, and responses to drugs of abuse. It is speculated that these... 
TRANSMITTER RELEASE | PRESYNAPTIC INHIBITION | IN-VIVO | ULTRASTRUCTURAL-LOCALIZATION | DORSAL STRIATUM | RECEPTOR ACTIVATION | SYNAPTIC PLASTICITY | STRIATAL NEURONS | NEUROSCIENCES | MICE LACKING | NUCLEUS-ACCUMBENS | Synaptic Vesicles - metabolism | Electric Stimulation | Neostriatum - ultrastructure | Synaptic Transmission - physiology | Calcium Signaling - physiology | Presynaptic Terminals - ultrastructure | Substantia Nigra - metabolism | Receptors, Dopamine D2 - metabolism | Excitatory Postsynaptic Potentials - drug effects | Exocytosis - physiology | Cerebral Cortex - metabolism | Exocytosis - drug effects | Cerebral Cortex - ultrastructure | Excitatory Postsynaptic Potentials - physiology | Neural Inhibition - physiology | Neostriatum - drug effects | Neostriatum - metabolism | Synaptic Transmission - drug effects | Afferent Pathways - drug effects | Cerebral Cortex - drug effects | Dopamine - metabolism | Afferent Pathways - metabolism | Presynaptic Terminals - drug effects | Pyridinium Compounds | Synaptic Vesicles - ultrastructure | Quaternary Ammonium Compounds | Afferent Pathways - ultrastructure | Mice, Inbred C57BL | Receptors, Dopamine D2 - agonists | Amphetamine - pharmacology | Feedback - physiology | Mice, Knockout | Feedback - drug effects | Substantia Nigra - drug effects | Animals | Calcium Signaling - drug effects | Substantia Nigra - ultrastructure | Presynaptic Terminals - metabolism | Synaptic Vesicles - drug effects | Glutamic Acid - metabolism | Mice | Neural Inhibition - drug effects | Dopamine | Microscopy | Charitable foundations | Neurons | Rodents
Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 03/2013, Volume 38, Issue 4, pp. 552 - 562
The abuse of psychoactive 'bath salts' containing cathinones such as 3,4-methylenedioxypyrovalerone (MDPV) is a growing public health concern, yet little is... 
cathinone | monoamine transporter | uptake blocker | dopamine | designer drug | NOREPINEPHRINE | PSYCHIATRY | DOPAMINE OVERFLOW | LOCOMOTOR-ACTIVITY | MEPHEDRONE | MONOAMINE TRANSPORTERS | NEUROSCIENCES | NUCLEUS-ACCUMBENS | LEGAL HIGHS | DRUGS | PHARMACOLOGY & PHARMACY | D-AMPHETAMINE | UPTAKE INHIBITORS | Motor Activity - physiology | Humans | Motor Activity - drug effects | Male | Corpus Striatum - metabolism | Pyrrolidines - pharmacology | Salts - chemistry | Salts - pharmacology | Psychotropic Drugs - pharmacology | HEK293 Cells | Benzodioxoles - chemistry | Dopamine - metabolism | Organ Culture Techniques | Cocaine - chemistry | Designer Drugs - pharmacology | Mice, Inbred C57BL | Rats | Psychotropic Drugs - chemistry | Random Allocation | Pyrrolidines - chemistry | Rats, Sprague-Dawley | Cocaine - pharmacology | Designer Drugs - chemistry | Animals | Corpus Striatum - drug effects | Mice | Benzodioxoles - pharmacology | Neurochemistry | Brain | Drug abuse | Salts | Dopamine | Intravenous administration | Brain slice preparation | Catecholamines | Data processing | Pharmacology | Nucleus accumbens | Side effects | Tachycardia | Monoamine transporter | Neostriatum | Cocaine | Locomotor activity | Neurotransmission | Public health | addiction & Substance Abuse | blocker | catecholamines | releaser | designer drugs | neuropharmacology | transporter | Original | Psychostimulants
Journal Article
Journal Article
Biological Psychiatry, ISSN 0006-3223, 2014, Volume 75, Issue 9, pp. 711 - 722
Background L-3,4-dihydroxyphenylalanine (L-DOPA)–induced dyskinesia is an incapacitating complication of L-DOPA therapy that affects most patients with... 
Psychiatry | three-dimensional neuronal reconstruction | medium spiny neuron | striatum | Behavioral sensitization | L-DOPA | dyskinesia | Parkinson’s disease | Parkinson's disease | RAT NEOSTRIATUM | HEMIPARKINSONIAN MICE | PSYCHIATRY | D-1 | NEUROSCIENCES | NUCLEUS-ACCUMBENS | DENDRITIC SPINES | LEVODOPA-INDUCED DYSKINESIA | STRIATAL NEURONS | EXPRESSION | PARKINSONS-DISEASE | Neurons - pathology | Dyskinesia, Drug-Induced - physiopathology | Cerebral Cortex - pathology | Male | Oxidopamine | Receptors, Dopamine D2 - metabolism | Cerebral Cortex - physiopathology | Receptors, Dopamine D1 - metabolism | Antiparkinson Agents - therapeutic use | Dendritic Spines - drug effects | Parkinsonian Disorders - drug therapy | Neurons - physiology | Receptors, Dopamine D1 - agonists | Cerebral Cortex - drug effects | Neurons - drug effects | Corpus Striatum - pathology | Membrane Potentials - drug effects | Dopamine Agonists - pharmacology | Parkinsonian Disorders - physiopathology | Corpus Striatum - physiopathology | Levodopa - therapeutic use | Mice, Inbred C57BL | Dendritic Spines - physiology | Proto-Oncogene Proteins c-fos - metabolism | Mice, Transgenic | Dyskinesia, Drug-Induced - pathology | Membrane Potentials - physiology | Antiparkinson Agents - adverse effects | Animals | Parkinsonian Disorders - pathology | Dendritic Spines - pathology | Levodopa - adverse effects | 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine - pharmacology | Corpus Striatum - drug effects | Phenols | Dopamine | Dopa | Neurons | Movement disorders | Resveratrol | Index Medicus
Journal Article
Nuclear Medicine and Biology, ISSN 0969-8051, 2015, Volume 43, Issue 2, pp. 158 - 164
Journal Article